The National Medical Products Administration (NMPA) oversees the regulation and approval of medical device clinical trials in China. It ensures compliance with safety and efficacy standards, reviews trial protocols, grants necessary approvals, and monitors post-market surveillance to protect public health and ensure high-quality medical devices.
